Inventor
JUNUTULA JAGATH R
US19 patents
⚠️ This page may combine multiple inventors who share the name “JUNUTULA JAGATH R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENENTECH INC
10 patentsUS7723485B2May 25, 2010
Cysteine engineered anti-MUC16 antibodies and antibody drug conjugates
GENENTECH INC286 citations98
US8617559B2Dec 31, 2013
Anti-FcRH5 antibodies and immunoconjugates and methods of use
GENENTECH INC19 citations92
US8362213B2Jan 29, 2013
Anti-FcRH5 antibodies and immunoconjugates and methods of use
GENENTECH INC28 citations92
US9360484B2Jun 7, 2016
Anti-FcRH5 antibodies and immunoconjugates and methods of use
GENENTECH INC7 citations83
US9017951B2Apr 28, 2015
Anti-FcRH5 antibodies and immunoconjugates and methods of use
GENENTECH INC7 citations83
US10604557B2Mar 31, 2020
Cysteine engineered antibodies and conjugates
GENENTECH INC1 citations71
US10077318B2Sep 18, 2018
Cysteine engineered antibodies and conjugates
GENENTECH INC5 citations64
US11873330B2Jan 16, 2024
Cysteine engineered antibodies and conjugates
GENENTECH INC0 citations61
USRE47194EJan 8, 2019
Cysteine engineered anti-MUC16 antibodies and antibody drug conjugates
GENENTECH INC0 citations51
US9580514B2Feb 28, 2017
Compositions and methods for the diagnosis and treatment of tumor
GENENTECH INC0 citations50
CELLERANT THERAPEUTICS INC
5 patentsUS9974864B2May 22, 2018
Isoquinolidinobenzodiazepines
CELLERANT THERAPEUTICS INC6 citations83
US11072662B2Jul 27, 2021
Humanized anti-CLL-1 antibodies
CELLERANT THERAPEUTICS INC2 citations72
US10898580B2Jan 26, 2021
Isoquinolidinobenzodiazepines
CELLERANT THERAPEUTICS INC2 citations72
US9504694B2Nov 29, 2016
Isoquinolidinobenzodiazepines
CELLERANT THERAPEUTICS INC3 citations72
US10350218B2Jul 16, 2019
Isoquinolidinobenzodiazepine (IQB)-1(chloromethyl)-2,3-dihydro-1H-benzo[e]indole (CBI) dimers
CELLERANT THERAPEUTICS INC1 citations56